Jazz Pharmaceuticals plc (NasdaqGS:JAZZ) is looking for M&A. Renee Gala said, "As we look at what's in our business today, we have a ton to be excited about, a lot to be able to invest in. And we think there's opportunity in this market to be active, both on the licensing as well as the M&A front".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
108.8 USD | -1.01% | -1.88% | -11.52% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.52% | 6.79B | |
+25.46% | 659B | |
+25.81% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.00% | 215B | |
+7.53% | 210B | |
-6.30% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Jazz Pharmaceuticals Seeks M&A